Modulation of anxiety through blockade of anandamide hydrolysis
CA 2501506 C · Owner: Universita Degli Studi Di Urbino · Inventors: Piomelli, Daniele; Tontini, Andrea; Duranti, Andrea
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Fatty acid amide hydrolase inhibitors of the Formula (I) are provided wherein , X is NH, CH2, O, or S; Q is O or S; Z is O or N; R is an aromatic moiety selected from the group consisting of substituted or unsubstituted aryl; substituted or unsubstituted biphenylyl substituted or unsubstituted , naphthyl and substituted or unsubstituted phenyl; substituted or unsubstituted terphenylyl; substituted or unsubstituted cycloalkyl heteroaryl, or alkyl; and R1 and R2 are independently selected from the group consisting of H, substituted or unsubstituted alkyl substituted or , unsubstituted heteroalkyl and substituted or unsubstituted phenyl substituted or unsubstituted biphenylyl substituted …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 7, 2003 and granted February 11, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 7, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 7, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.